Wockhardt gets FDA's blessing for generic ZytigaWockhardt's generic of Johnson & Johnson's branded metastatic prostate cancer treatment will be available in a 250-mg dosage strength. Camber unveils generic CialisCamber's generic Cialis is available in several dosage strengths. Alembic gets FDA OK for generic Optivar Azelastine hydrochloride ophthalmic solution had a market value of roughly $8.5 million for the 12 months ended December 2018, according to IQVIA. Teva launches generic Exjade Exjade had a market value of $134 million for the year ended December 2018, according to IQVIA data. Slayback gets FDA nod for single-dose generic Makena The company previously launched its generic Makena in a 5 ml multidose vial. Hikma launches Levophed generic Norepinephrine bitartrate injection had a market value of roughly $97 million for the 12 months ended January 2019. Zydus Cadila receives FDA nod for generic Latuda Zydus Cadila's generic Latuda tablets provide a treatment for certain mental/mood disorders. Perrigo names new CFO Ray Silcock is Perrigo's new executive vice president and CFO, replacing Ronald Winowiecki, who is resigning. Novo Nordisk, Teva ink generic Victoza settlement Teva is licensed to launch a generic version of Victoza as of Dec. 22, 2023 as the result of its settlement with Novo Nordisk, which manufactures the branded version of the drug. FDA approves Zydus Cadila’s generic Zovirax ointment Zydus Cadila's generic Zovirax will be available in 5% strength. First Previous 195 196 197 198 199 Next Last
